Interview with CEO of American Gene Technologies, Jeff Galvin

About BioNeex | https://bioneex.com BioNeex is the first open exchange platform for R&D-stage licensing and collaborative partnerships in the biopharmaceutical industry. At BioNeex we work together with research institutions, biotechnology and biopharmaceutical companies that are discovering and developing innovative compounds by connecting them through our online biopharma R&D exchange platform. Helping our clients to gain for their compounds a vital exposure to the right partners at the right time will increase the likelihood to get these innovative compounds into the clinic and, ultimately, to the patients as novel medicines. In essence, BioNeex provides an online infrastructure for biopharmaceutical, biotech companies and research institutions, where they can meet and partner. The BioNeex Interviews simply are part of the BioNeex vision, which is providing exposure to biotech companies and their R&D pipelines in order to find the right licensing and co-development partners without spending lots of time and money on conferences. About American Gene Technologies | https://www.americangene.com American Gene Technologies is a Maryland, US-based biotech company developing novel gene and cell therapeutics in large and orphan indications, infectious diseases, immuno-oncology, and monogenic disorders based on its proprietary viral vector platform.